Episode 66: COVID-19 Policy Implications and Preliminary Clinical Data With Emily Landon

Episode 66: COVID-19 Policy Implications and Preliminary Clinical Data With Emily Landon

Emily Landon, MD, executive medical director of infection prevention and control, University of Chicago, returns to discuss crucial considerations for reopening the country, reactions to the way infection control experts have handled new information, and the overreaction to a recent preliminary report from the University of Chicago on a potential treatment option.

Related Resources

More about Emily Landon:  Univ of Chicago

This podcast is produced by the Journal of Clinical Pathways.

Subscribe to Healthcare Unfiltered

Other Episodes You May Enjoy...

Episode 206: Fireside Chat With Joe Mikhael, the CMO of the IMF

Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding

Read More

Episode 205: Multi-Cancer Early Detection (MCED): Now and Later

Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary

Read More